| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $215.0M | +49.0% |
| Cost of Revenue | $74.0M | +41.7% |
| R&D Expense | $286.4M | -50.0% |
| SG&A Expense | $259.0M | +18.3% |
| Operating Income | -$404.4M | +42.2% |
| Interest Expense | $0 | — |
| Pre-tax Income | -$443.3M | +37.1% |
| Income Tax | $0 | — |
| Net Income | -$443.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.01B | +4.6% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $40.0M | -15.8% |
| Inventory | $31.6M | +66.9% |
| Current Assets | $1.12B | -25.1% |
| Total Assets | $1.22B | -24.2% |
| Current Liabilities | $139.8M | -27.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$367.6M | +33.1% |
| Capital Expenditures | $24.6M | +34.4% |
| Investing Cash Flow | $420.0M | +68.0% |
| Financing Cash Flow | -$1.7M | -100.2% |
| Free Cash Flow | -$392.2M | +30.9% |
| +37.1% |
| EPS (Basic) | -$0.46 | +39.5% |
| EPS (Diluted) | -$0.46 | +39.5% |
| Total Liabilities |
| $174.5M |
| -24.1% |
| Stockholders' Equity | $1.05B | -24.2% |